---
$id: https://graph.org.ai/products/commodity/51152033
$type: Product
source: UNSPSC
code: "51152033"
title: "Inaperisone"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Inaperisone

**UNSPSC Code**: 51152033
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C16H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0QAC3P785O, chemically known as 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-pyrrolidinyl)-, but generally known as inaperisone, which bears US NIH Compound Identifier 65860. European Medicines Agency schedules Inaperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08162MIG. The term INAPERISONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). INAPERISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule inaperisone under HS 29339990 and SITC 51577. As of Q4 2014, INAPERISONE remains the US FDA Preferred Term for this commodity. Inaperisone bears US NLM identifiers UMLS ID C0062996 and NCI Concept Code C65905. SMILES: O=C(C(CN1CCCC1)C)C1CCC(CC1)CC.

